Kinetics of BCR-ABL after TKI Interruption during Pregnancy in CML: A Multinational Retrospective Analysis

被引：4
作者：
Lee, Jeong-Ok [1 ]
Kim, Dong-Wook [2 ]
Abruzzese, Elisabetta [3 ]
Apperley, Jane [4 ]
Caldwell, Louise [5 ]
Mauro, Michael J. [6 ]
机构：
[1] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hosp, Catholic Blood & Marrow Transplantat Ctr, Leukemia Res Inst,Dept Hematol,Coll Med, Seoul, South Korea
[3] S Eugenio Hosp, Haematol Unit, Rome, Italy
[4] Imperial Coll London, Ctr Haematol, London, England
[5] Univ Birmingham, Med Sch, Sheffield, S Yorkshire, England
[6] Mem Sloan Kettering Canc Ctr, Myeloproliferat Neoplasms Program, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-119615
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4263
引用
收藏
页数：4
相关论文
共 50 条
  • [21] DETECTION OF BCR-ABL TRANSCRIPTS BY PCR IN PATIENTS 10 YEARS OR MORE AFTER BMT FOR CML
    LIN, F
    VANRHEE, F
    CROSS, NCP
    GOLDMAN, JM
    [J]. BLOOD, 1993, 82 (10) : A215 - A215
  • [22] DETECTION OF PERSISTING BCR-ABL MESSENGER-RNA BY PCR AFTER BMT IN CML PATIENTS
    MARTINELLI, G
    GUERRASIO, A
    SESSAREGO, M
    ROSSO, C
    SCARAVAGLIO, P
    TESTONI, N
    ROSTI, G
    ZACCARIA, A
    IZZI, T
    FRASSONI, F
    GASPARINI, P
    AMBROSETTI, A
    DIBARTOLOMEO, A
    CHIAMENTI, M
    PIGNATTI, PF
    SAGLIO, G
    [J]. EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 540 - 540
  • [23] A QUANTITATIVE PCR TECHNIQUE FOR MONITORING CHANGING LEVELS OF BCR-ABL TRANSCRIPTS AFTER BMT FOR CML
    CROSS, NCP
    FENG, L
    GOLDMAN, JM
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 : 7 - 7
  • [24] Abnormally small BCR-ABL transcripts in CML patients before and during imatinib treatment.
    Khorashad, Jamshid S.
    Lipton, Jeffrey H.
    Marin, David
    Milojkovic, Dragana
    Cross, Nicholas C. P.
    Dibb, Nicholas
    Melo, Junia V.
    Kamel-Reid, Suzanne
    Goldman, John M.
    Apperley, Jane F.
    Kaeda, Jaspal S.
    [J]. BLOOD, 2006, 108 (11) : 611A - 611A
  • [25] BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients
    M Marega
    R G Piazza
    A Pirola
    S Redaelli
    A Mogavero
    I Iacobucci
    I Meneghetti
    M Parma
    E M Pogliani
    C Gambacorti-Passerini
    [J]. Leukemia, 2010, 24 : 1445 - 1449
  • [26] Sequential emergence of ABL-kinase mutations with loss of unmutated BCR-ABL allele during targeted therapies of CML
    Sorel, Nathalie
    Roy, Lydia
    Martineau, Geraldine
    Guilhot, Francois
    Turhan, Ali G.
    Chomel, Jean-Claude
    [J]. BLOOD, 2006, 108 (05) : 1782 - 1783
  • [27] BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients
    Marega, M.
    Piazza, R. G.
    Pirola, A.
    Redaelli, S.
    Mogavero, A.
    Iacobucci, I.
    Meneghetti, I.
    Parma, M.
    Pogliani, E. M.
    Gambacorti-Passerini, C.
    [J]. LEUKEMIA, 2010, 24 (08) : 1445 - 1449
  • [28] Dynamics of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia (CML) after treatment with one, two or three tyrosine kinase inhibitors (TKI).
    Jabbour, Elias
    Jones, Dan
    Kantarjian, Hagop
    O'Brien, Susan
    Garcia-Manero, Guillermo
    Giles, Francis
    Wierda, William
    Cortes, Jorge
    [J]. BLOOD, 2006, 108 (11) : 225A - 225A
  • [29] Does BCR-ABL genomic rearrangement persist in CML patients in complete remission after interferon α therapy?
    F Brizard
    JC Chomel
    A Veinstein
    J Rivet
    C Giraud
    A Kitzis
    F Guilhot
    A Brizard
    [J]. Leukemia, 1998, 12 : 1076 - 1080
  • [30] Does BCR-ABL genomic rearrangement persist in CML patients in complete remission after interferon α therapy?
    Brizard, F
    Chomel, JC
    Veinstein, A
    Rivet, J
    Giraud, C
    Kitzis, A
    Guilhot, F
    Brizard, A
    [J]. LEUKEMIA, 1998, 12 (07) : 1076 - 1080
12345